Speaker List

2016 Speaker List

Adrian Ray, Ph.D., Senior Director, Department of Drug Metabolism, Gilead Sciences, Inc.

Adrian Whitty, Ph.D., Associate Professor, Chemistry, Boston University

Alan Mathiowetz, Director, Worldwide Medicinal Chemistry, Cardiovascular and Metabolic Diseases, Pfizer

Aleksander Skardal, Ph.D., Assistant Professor, Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine

Alexandra Glucksmann, Ph.D., COO, Editas Medicine

Alexandre Prat, M.D., Ph.D., FRCPC, Professor, Neuroscience, Université de Montréal

Amit Vasanji, Ph.D. Chief Technology and Scientific Officer ImageIQ

Andreas Reichel, Ph.D., Vice President, Head, Research Pharmacokinetics, Bayer Pharma

Andrew Alt, Ph.D., Senior Research Investigator, Lead Discovery, Bristol-Myers Squibb

Andrew P. Combs, Ph.D., Vice President, Medicinal Chemistry, Incyte Corporation

Andrew Wang, M.D., Associate Professor, Director of Clinical and Translational Research, Department of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina,Chapel Hill

Angelica Loskog, Professor, IGP, Uppsala University, CEO, Lokon Pharma AB

Anna Coulon Spektor, CDD Customer Success Manager, Support and Training, Collaborative Drug Discovery

Anne Mai Wassermann, Ph.D., Senior Scientist, Molecular Informatics, Pfizer

Annette Byrne, Ph.D., Senior Lecturer Physiology & Medical Physics, Royal College of Surgeons in Ireland

Annick D. Van Den Abbeele, M.D., Associate Professor, Radiology, Harvard Medical School; Chief, Department of Imaging, Dana-Farber Cancer Institute; Founding Director, Center for Biomedical Imaging in Oncology (CBIO), Imaging, Dana-Farber Cancer Institute

Annie Frelet-Barrand, Ph.D., CNRS Researcher, Institute FEMTO-ST, Besançon, France

Arijit Chakravarty, Ph.D., Director, Modeling and Simulation (DMPK), Takeda Pharmaceuticals International Co.

Aron Jaffe, Ph.D., Senior Investigator, Regenerative Medicine Hub Leader, Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research

Atli Thorarensen, Ph.D, Research Fellow, BioTx Medicinal Chemistry, Pfizer

Barry A. Morgan, Ph.D., Visiting Professor, Institute for Molecular Medicine, University of Texas Health Sciences

Beau Webber, Ph.D., Director, Stem Cell Technologies, B-MoGen Biotechnologies, Inc.

Benjamin Cuiffo, Ph.D., Scientist, Biomodels LLC

Berislav Zlokovic, M.D., Ph.D., Director, Zilkha Neurogenetic Institute, Keck School of Medicine

Bilada Bilican, Ph.D., Investigator II, Neuroscience, Novartis Institutes for BioMedical Research (NIBR)

Bo Feng, Ph.D., Senior Principal Scientist, Pharmacokinetics, Dynamics, and Drug Metabolism, Pfizer, Inc.

Brandon Lamarche, Ph.D., Research Scientist, Research & Development, ACEA Biosciences

Brian D. Lichty, Ph.D., Associate Professor, Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University

Brian Pate, Physical Scientist, Chemical and Biological Technologies Department, Defense Threat Reduction Agency

Bruce R. Zetter, Ph.D., Charles Nowiszewski Professor of Cancer Biology, Department of Surgery, Harvard Medical School

C. Shad Thaxton, M.D., Ph.D., Assistant Professor, Northwestern University, Feinberg School of Medicine

Carl Webster, Ph.D., Principal Scientist, Antibody Discovery and Protein Engineering, MedImmune

Carrie Northcott, Ph.D., Senior Principal Scientist, Global Safety Pharmacology, Pfizer Inc.

Carsten Carstens, Ph.D., Research & Development, Sr. Scientist, Molecular Biology, Genomics, Agilent Technologies

Cem Girit, Ph.D., Biopticon Corporation

Ceren Korkut, Ph.D., Scientist, Biogen

Chad Cowan, Ph.D., Associate Professor, Harvard Department of Stem Cell & Regenerative Biology (HSCRB)

Changyu Wang, Ph.D., Director, Cancer Immunology, Pfizer

Christoph Funk, Ph.D., Vice Director, Pharmaceutical Sciences, F. Hoffmann La-Roche

Chudi Ndubaku, Ph.D., Associate Director, Organic Synthetic Chemistry, Aduro Biotech, Inc.

Collin Edington, Ph.D., Research Scientist, Linda Griffith Laboratory, Biological Engineering, Massachusetts Institute of Technology

Cory Abate-Shen, Ph.D., Michael and Stella Chernow Professor of Urological Oncology, Associate Director, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center

Cyril H. Benes, Ph.D., Principal Investigator and Director, Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center

Dai Fukumura, M.D., Ph.D., Deputy Director, Edwin L. Steele Laboratory; Biologist, Department of Radiation Oncology, Massachusetts General Hospital; Associate Professor, Harvard Medical School

Dan Duda, D.M.D., Ph.D., Associate Professor, Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School

Dan Ortwine, Principal Scientist, Discovery Chemistry, Genentech

Daniel Abate-Daga, Ph.D., Assistant Member, Immunology Program, H. Lee Moffitt Cancer Center and Research Institute

Daniel E Bauer M.D., Ph.D., Assistant Professor of Pediatrics, Harvard Medical School and Staff Physician in Pediatric Hematology/Oncology, Boston Children’s Hospital and Dana-Farber Cancer Institute, Principal Faculty, Harvard Stem Cell Institute

Daniel G. Anderson, Ph.D., Professor, Department of Chemical Engineering, Institute for Medical Engineering & Science, Harvard-MIT Division of Health Sciences & Technology and David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology

Daniela Cipolletta, Ph.D., Research Investigator, Clinical Translational Oncology, TCO, Novartis Oncology

Danilo Maddalo, Ph.D., Lab Head, ONC Pharmacology, Novartis Institutes for BioMedical Research

Dario Doller, Ph.D., Independent Consultant

Dario O. Fauza, M.D., Ph.D., Associate in Surgery, Boston Children's Hospital; Associate Professor, Surgery, Harvard Medical School

Darrell Borger, Ph.D., Director, MGH Biomarker/Translational Research Laboratory, Cancer Center, Massachusetts General Hospital

Dave Parry, Ph.D., COO, Cyclofluidic

David DeGoey, Ph. D., Sr. Principal Research Scientist, Discovery Chemistry and Technology, AbbVie

David Hepworth, Ph.D., Senior Director, Worldwide Medicinal Chemistry, Pfizer

David Largaespada, Ph.D., CSO, Surrogen, Inc.

David Swinney, CEO, iRND3, Institute for Rare and Neglected Diseases

David Thompson, Ph.D., Research & Development, Manager, ADME/Tox, MilliporeSigma

Derek S. Tan, Ph.D., Chairman, Member, and Tri-Institutional Professor, Chemical Biology Program, Memorial Sloan Kettering Cancer Center

Dominic G. Spinella, Ph.D., Executive Director, Medical Sciences, Head of Clinical

Douglas E. Linn, Ph.D., Senior Scientist, Merck Research Laboratories

E. Antonio Chiocca, M.D., Harvey W. Cushing Professor of Neurosurgery, Neurosurgeon-in-Chief and Chairman, Department of Neurosurgery, Co-Director, Institute for the Neurosciences, Brigham and Women’s/ Faulkner Hospital, Surgical Director, Center for Neuro-oncology, Dana-Farber Cancer Institute

Ed Champness, CSO, Optibrium

Edward J. Hennessy, Ph.D., Associate Principal Scientist, Oncology iMed, Chemistry, Innovative Medicines and Early Development, AstraZeneca

Enrique Escandón, Ph.D., Senior Principal Scientist, DMPK and Disposition, Merck

Erik Hett, Ph.D., Team Leader and Senior Scientist, Chemical Biology, Biogen

Erin Keaney, Ph.D., Investigator III, Novartis Institutes for BioMedical Research

Esmaiel Jabbari, Ph.D., Professor, Chemical Engineering, University of South Carolina

Falgun Shah, Ph.D., Principal Scientist, Computational Toxicologist, Molecular Informatics, Pfizer

Faris Farassati, Ph.D, PharmD, Cancer Scientist, Marion and Henry Bloch Foundation Neuro-oncology Researcher, Midwest Biomedical Research Foundation, Kansas City Veteran Affairs Medical Center

Filippos Tourlomousis, Research Assistant, Mechanical Engineering, Stevens Institute of Technology

Greg Luerman, Ph.D., Head, Applications Development, Axiogenesis Inc

Gregory Alberts, Ph.D., Global Subject Matter Expert, Lonza

Gus Frangou, Ph.D., Director, Research & Development, Cellecta, Inc.

Hang Hubert Yin, Ph.D., Associate Professor, Department of Chemistry and Biochemistry, University of Colorado, Boulder

Hannes Hahne, Ph.D. CEO, OmicScouts GmbH

Hao Chen, Ph.D., Senior Scientist, Protein Technologies, Amgen, Inc.

Helmut Thomas, Ph.D., DABT, President and CEO, Cyclenium Pharma, Inc.

Henning Mann, Ph.D., Senior Research Scientist, Research & Development, Nortis, Inc.

Hisataka Kobayashi, M.D., Ph.D., Chief Scientist, Molecular Imaging Program, NCI/NIH

Holger Karsunky, Ph.D., Director, Cancer Biology, Stemcentrx, Inc.

Huabiao Chen, M.D., Ph.D., Principal Investigator, Vaccine and Immunotherapy Center, Massachusetts General Hospital

Ivan Cornella Taracido, Ph.D., Senior Principal Scientist, Merck Research Laboratories

Jacalyn Rosenblatt, M.D., Assistant Professor, Department of Medicine, Harvard Medical School

Jacqueline Doody, Ph.D., Vice President, Immunology, F-star Biotechnology, Ltd

James J. Hickman, Ph.D., Founding Director, NanoScience Technology Center; Professor, Nanoscience Technology, Chemistry, Biomolecular Science, Material Science and Electrical Engineering, University of Central Florida

James Kramer, Ph.D., Principal Scientist, Discovery, Charles River

James U. Bowie, Ph.D., Professor and Vice Chair, Department of Chemistry and Biochemistry, University of California, Los Angeles

Jan Wahlstrom, Ph.D., Director, Pharmacokinetics and Drug Metabolism, Amgen

Jason Ekert, Ph.D., Senior Research Scientist, Biologics Research, Janssen BioTherapeutics

Jeffrey Kumer, MSc, Client Services Specialist, Animal Study Workflow Solutions, Studylog Systems, Inc.

Jeffrey Morgan, Ph.D., Professor, Medical Science, Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University

Jeffrey Stock, Ph.D., Principal Scientist, Global R&D Groton Labs, Pfizer

Jeffrey T. Borenstein, Ph.D., Laboratory Technical Staff, Biomedical Microsystems, Draper Laboratory

Jessica Kirshner, Ph.D., Director, Oncology and Angiogenesis, Regeneron Pharmaceuticals

Jianguo Ma, Ph.D., Associate Direcotr, Translational In Vivo Pharmacology, EMD Serono R&D

Jing (Jeannie) Li, Ph.D., Senior Scientist, Medicinal Chemistry Chemical Biology, Pfizer

Jinjun Shi, Ph.D., Assistant Professor, Harvard Medical School, Director, Laboratory for Nanoengineering & Drug Delivery, Brigham and Women’s Hospital

Joe Conner, Ph.D., CSO, Research and Development, Virttu Biologics, Ltd.

Joerg Holenz, Ph.D., Director, Discovery and Preclinical Sciences; Project Leader, Neuroscience iMed, AstraZeneca Neuroscience

John Bell, Ph.D., Senior Scientist, Centre for Innovative Cancer Research, Ottawa Hospital Research Institute, Professor, Departments of Medicine and Biochemistry, Microbiology & Immunology, University of Ottawa

John Doench, Ph.D., Associate Director, Genetic Perturbation Platform, Broad Institute of Harvard and MIT

John Howe, Ph.D., Principal Scientist, Infectious Diseases, Merck & Co.

John Reilly, Ph.D., Senior Research Investigator, Global Discovery Chemistry, Novartis Institute of Biomedical Research

John Swart, Ph.D., President, Exemplar Genetics

Jonathan Garlick, D.D.S, Ph.D., Professor, School of Dental Medicine, Tufts University; Director, Division of Cancer Biology and Tissue Engineering, Tufts School of Medicine, School of Engineering and Sackler School of Graduate Biomedical Sciences

Jonathan Gootenberg, Member, Laboratories of Dr. Aviv Regev and Dr. Feng Zhang, Department of Systems Biology, Harvard Medical School, and Broad Institute of Harvard and MIT

Jorge Alvarez, Ph.D., Assistant Professor, Pathobiology, University of Pennsylvania

Joseph Klim, Ph.D., Postdoctoral Scholar, Eggan Lab, Stem Cell and Regenerative Biology Department, Harvard University

Jung Weon Lee, Ph.D., Professor, Department of Pharmacy, College of Pharmacy, Seoul National University

Kap-Sun Yeung, Ph. D., Principal Scientist, Discovery Chemistry, Bristol-Myers Squibb

Karl Griswold, Ph.D., Associate Professor of Engineering, Thayer School of Engineering, Dartmouth College

Karuppiah Kannan, Ph.D., Associate Director, Cancer Pharmacology, Takeda Pharmaceuticals International

Katherine L. Lee, Ph.D., Associate Research Fellow, Worldwide Medicinal Chemistry, Pfizer

Kenna Anderes, Ph.D., Founder & President, Translational Medicine Partners, Inc.

Kevin C. Eggan, Ph.D., Harvard Department of Stem Cell and Regenerative Biology, Howard Hughes Medical Institute

Khalid Shah, Ph.D., Associate Professor, Harvard Medical School, Director, Molecular Neurotherapy and Imaging Laboratory, Director, Stem Cell Therapeutics and Imaging Program, Department of Radiology and Neurology, Massachusetts General Hospital

Kimberly B. Kegel-Gleason, Ph.D., Assistant Professor in Neurology, Massachusetts General Hospital & Harvard Medical School

Krzysztof Masternak, Ph.D., Head, Biology, Therapeutic Antibody Discovery, Novimmune

Kullervo Hynynen, Ph.D., Professor, Medical Biophysics, University of Toronto

Laszlo Urban, M.D., Ph.D., Global Head, Preclinical Secondary Pharmacology, Novartis Institutes for BioMedical Research, Inc.

Lata Jayaraman, Ph.D., Director, Pharmacology and Translational Research, Cerulean Pharma

Leah Norona, Doctoral Candidate Curriculum in Toxicology, University of North Carolina at Chapel Hill

Leonard Khiroug, CSO, Neurotar Ltd.

Leoni Kunz-Schughart, Ph.D., Professor, Tumor Pathophysiology, OncoRay, National Center for Radiation Research in Oncology

Lois A. Lampson, Ph. D., Associate Professor of Neurosurgery, Brigham & Women’s Hospital, Harvard Medical School

Lois A. Lampson, Ph.D., Associate Professor of Neurosurgery, Brigham & Women’s Hospital, Harvard Medical School

Ludovic Collin, Laboratory Head, pRED RICB, F. Hoffmann-La Roche

Luke MacQueen, Ph.D., Research Scientist, Disease Biophysics Group, Wyss Institute for Biologically Inspired Engineering; John A. Paulson School of Engineering and Applied Sciences, Harvard University

Lyn Jones, Ph.D., Head, Rare Diseases Chemistry; Head, Chemical Biology, Pfizer

Lynsey Whilding, Ph.D., Research Associate, CAR Mechanics Group, Research Oncology, Division of Cancer Studies, King’s College London

M. Paola Castaldi, Ph.D., Head, Chemical Biology Team, Discovery Sciences, R&D Boston, AstraZeneca

Madhu Lal-Nag, Ph.D., Group Leader, Trans-NIH RNAi Facility, National Center for Advancing Translational Sciences, National Institutes of Health

Mahmud Bani, Ph.D., Team Leader and Senior Research Officer, Translational Bioscience, National Research Council Canada

Manfred Kraus, Ph.D., Director, in vivo Pharmacology, Tumor Cell Biology, Pfizer Oncology

Mark Throsby, Ph.D., CSO, Merus

Mark Wolf, Ph.D., Section Head, Medicinal Chemistry, Albany Molecular Research, Inc.

Martin Graf, Ph.D., Director, Charles River Labs

Martin Treder, Ph.D., CSO, R&D, Affimed

Mary Ellen Cvijic, Ph.D., Principal Scientist, Department of Lead Discovery and Optimization, Bristol-Myers Squibb

Matt Gevaert, Ph.D., CEO & Co-founder, KIYATEC

Matthew Bogyo, Ph.D., Professor, Pathology, Microbiology and Immunology; Professor by Courtesy, Chemical and Systems Biology, Stanford School of Medicine

Matthew David Disney, Ph.D., Professor, Department of Chemistry, The Scripps Research Institute

Matthew Robers, Senior Research Scientist & Group Leader, Research & Development, Promega Corporation

Michael Bassik, Ph.D., Assistant Professor, Department of Genetics, Stanford University

Michael Seiler, Ph.D., Portfolio Director, Commercial Genetically Engineered Models, Taconic Biosciences

Ming Zhao, Ph.D., Associate Professor, Feinberg School of Medicine, Northwestern University

Mingxiang Liao, Ph.D., Senior Scientist I, DMPK, Takeda Pharmaceutical Intl. Company

Mitchell Ho, Ph.D., Head, Antibody Therapy Section, Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute

Monica Moya, Ph.D., Research Engineer, Materials Engineering Division, Lawrence Livermore National Laboratory

Murat Cirit, Ph.D., Director, Translational Systems Pharmacology, DARPA-PhysioMimetics Program, Massachusetts Institute of Technology

Myung Shin, Ph.D., Senior Principal Scientist, Genetics and Pharmacogenomics, Merck & Co. Inc.

Namir Hassan, Ph.D., Director, Translational Research & Development, Immunocore Ltd.

Namjin Chung, Ph.D., Head, Functional Genomics Platform, Discovery Research, AbbVie, Inc.

Nastaran Hashemi, Ph.D., Assistant Professor, Department of Mechanical Engineering, College of Engineering, Iowa State University

Nathanael Gray, Ph.D., Professor, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School; Professor, Cancer Biology, Dana-Farber Cancer Institute

Neal Goodwin, Ph.D., Vice President, Corporate Research Development, Champions Oncology

Netanya Y. Spencer, M.D., Ph.D., Research Fellow in Medicine, Joslin Diabetes Center, Harvard Medical School

Nicholas A. Meanwell, Ph.D., Executive Director, Discovery Chemistry, Bristol-Myers Squibb

Nongjian Tao, Ph.D., Director, Center for Bioelectronics and Biosensors, Biodesign Institute and Professor of Electrical Engineering, Arizona State University

Norbert Perrimon, Ph.D., Professor, Department of Genetics, Harvard Medical School and Investigator, Howard Hughes Medical Institute

Olaf S. Andersen, M.D., Professor, Department of Physiology and Biophysics, Weill Medical College, Cornell University

Oliver Ghobrial, Ph.D., Senior Scientist III, Translational Modeling and Simulation, AbbVie

Osama Rahma, M.D., Assistant Professor, Center for Immune-Oncology, Dana-Farber Cancer Institute

Paloma H. Giangrande, Ph.D., Associate Professor, Department of Internal Medicine and Department of Radiation Oncology, University of Iowa

Paul Diehl, Ph.D., Director, Business Development, Cellecta, Inc.

Paul Richardson, Ph.D., Senior Principal Scientist, Discovery Chemistry, Pfizer

Paul Scola, Ph.D., Research Fellow, Department of Virology Chemistry, Bristol-Myers Squibb Pharmaceutical Research Institute

Paul W. Burridge, Ph.D., Assistant Professor, Department of Pharmacology, Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine

Pedro J. Beltran, Ph.D., Research Director, Oncology Research, Amgen, Inc.

Per-Ola Freskgard, Ph.D., Vice Director and Senior Leader, Neuroscience, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd.

Peter Wuelfing, Ph.D., Executive Director, Discovery Pharmaceutical Sciences, Merck & Co

Philippe Slos, Director, Scientific Operations, Oncodesign

Qiang Shi, Ph.D., Principal Investigator, Division of Systems Biology, National Center for Toxicological Research (NCTR), U.S. FDA

Qibin Su, Ph.D., Senior Scientist, Chemistry Department, Oncology iMED, AstraZeneca

Quang-Dé Nguyen, Ph.D., Director of the Lurie Family Imaging Center, Senior Scientist, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute

Ralph Garippa, Ph.D., Director, RNAi Core Facility, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center

Ralph Mazitschek, Ph.D., Assistant Professor, Center for Systems Biology, Chemical Biology Platform, Massachusetts General Hospital

Remi Villenave, Ph.D., Principal Investigator/R&D Lead, Emulate, Inc.

Richard Isaacs, Ph.D., Applied Research Sciences Manager, Molecular Sensing, Inc.

Richard Wooster, Ph.D., President of Research & Development, Blend Therpeutics, Inc.

Rick Huntress, Director, Business Development, In Vivo Services, The Jackson Laboratory

Robert A. Copeland, Ph.D., President of Research, CSO, Epizyme, Inc.

Robert A. Roth, Ph.D., DABT, Professor of Pharmacology and Toxicology and Director, Graduate Program in Environmental and Integrative Toxicological Sciences, Michigan State University

Robert Coffin, Ph.D., CEO & Founder, Replimune

Robert D. Bell, Ph. D., Principal Scientist, Integrative Neuroscience, Pfizer

Robert Foti, Senior Scientist, Pharmacokinetics and Drug Metabolism, Amgen, Inc.

Robert J. Young, Ph.D., Group Leader, NCE Medicinal Chemistry, GlaxoSmithKline

Robert L. Martuza, M.D., William and Elizabeth Sweet Professor of Neuroscience, Department of Surgery (Neurosurgery), Harvard Medical School, Chief, Neurosurgical Service, Attending Neurosurgeon, Massachusetts General Hospital

Robyn S. Klein, M.D., Ph.D., Professor, Internal Medicine, Pathology & Immunology, Anatomy & Neurobiology, Washington University School of Medicine

Rogier Buijsman, Ph.D., Head, Chemistry, Netherlands Translational Research Center B.V. (NTRC)

Ruben Boado, Ph.D., Vice President, R&D, Cofounder, ArmaGen

Rudolf Jaenisch, M.D., Founding Member, Whitehead Institute for Biomedical Research; Professor, Department of Biology, Massachusetts Institute of Technology

Saad Kenderian, M.D., Translational Research Program, Center for Cellular Immunotherapy, Laboratory of Dr. Carl June, University of Pennsylvania Medical School

Scot A. Wolfe, Ph.D., Associate Professor, Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School

Sergei Makarov, Ph.D., CEO, Attagene

Seyoum Ayehunie, Ph.D., Vice President, Immunological Systems, MatTek Corporation

Shanthi Ganesh, Ph.D., Associate Director, Pre-Clinical Oncology, Dicerna Pharmaceuticals

Sharon Benzeno, Ph.D., MBA, Vice President, Business Development, Adaptive Biotechnologies

Shila Mekhoubad, Ph.D., Scientist, Stem Cell Biology Lab, Biogen

Sidi Chen, Ph.D., Assistant Professor, Department of Genetics & Systems Biology Institute, Yale Cancer Center & Stem Cell Center

Stephanie Elmer, Ph.D., J.D., Associate, Biotechnology and Chemical Group, Sterne, Kessler, Goldstein & Fox

Stephanie Mohr, Ph.D., Lecturer, Genetics & Director of the Drosophila RNAi Screening Center, Harvard Medical School

Stephen H. White, Ph.D., Professor, Department of Physiology and Biophysics, School of Medicine, University of California at Irvine

Stevan W. Djuric, Ph.D., Senior Director, Discovery Chemistry and Technology, AbbVie, Inc.

Steve Yang, Ph.D., Product Specialist/Sales Rep, Northeastern Territory, IDEA Bio-Medical

Steven P. Gygi, Ph.D., Professor, Cell Biology, Harvard Medical School

Steven Rust, Ph.D., Senior Scientist, Antibody Discovery and Protein Engineering, MedImmune, Inc.

Stuart Shumway, Ph.D., Principal Scientist, Oncology Early Discovery, Merck Research Labs

Suresh Kumar, Ph.D., Director, R&D, Progenra, Inc.

Susan M.G. Goody, Ph.D., Senior Principal Scientist, Global Safety Pharmacology, Pfizer, Inc.

Svetlana Hamm, Ph.D., Head, Biology, Translational Pharmacology, 4SC Group

Terry Kenakin, Professor of Pharmacology in the Dept of Pharmacology, University of North Carolina School of Medicine

Terry Richard Stouch, Ph.D., President, Science for Solutions, LLC

Tim Briggs, Ph.D., Senior Director, Medicinal Chemistry, Ensemble Therapeutics

Timothy P. Heffron, Ph.D., Senior Scientist, Discovery Chemistry, Genentech, Inc.

Todd Wisialowski, MS, Associate Research Fellow, Global Safety Pharmacology, Pfizer Inc.

Tyler Miller, M.D./Ph.D. Candidate, Case Western Reserve School of Medicine, Stem Cell Biology and Regenerative Medicine, Jeremy Rich Lab, Cleveland Clinic

Vikram Khurana, M.D., Co-Founder and Vice President, Discovery Technologies, Yumanity Therapeutics

Viviana Cremasco, Ph.D., Investigator II, Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research

Wayne A. Marasco, M.D., Ph.D., Professor of Medicine, Dana-Farber Cancer Institute

William Elmquist, Pharm.D., Ph.D., Professor, Pharmaceutics, University of Minnesota

William Redmond, Ph.D., Associate Member, Laboratory of Cancer Immunotherapy, Earle A. Chiles Research Institute, Providence Portland Medical Center

Willie Quinn, Ph.D., President & CEO, Bullet Bio

Woody Sherman, Ph.D., Vice President, Applications Science, Schrödinger

Xi Yang, Ph.D., DABT, Principal Investigator, Division of Systems Biology, National Center for Toxicological Research (NCTR), U.S. FDA

Xiaofeng Cui, Ph.D., Professor & Department Chair, Department of Life Sciences and Technology, Wuhan University of Technology; Vice President, Research & Development, Stemorgan Therapeutics

Yoko Ejiri, Researcher, Microdevice Team, New Business Development Division, Kuraray Co. Ltd.

Yuan Wang, Ph.D., Investigator II, Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research

Yurong Lai, Ph.D., Senior Principal Scientist, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb

Yves Boucher, Ph.D., Associate Professor, Radiation Oncology, Harvard Medical School

Zhao Chen, Ph.D., Investigator III, Exploratory Immuno-Oncology, Novartis Institute of Biomedical Research

Zhonghua Pei, Ph.D., Senior Scientist, Genentech

Zoran Rankovic, Ph.D., Research Fellow, Discovery Chemistry Research & Technologies, Eli Lilly

Zsofia Kovacs, Ph.D., Postdoctoral Fellow, Radiology and Imaging Sciences, National Institutes of Health